Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gruber

Showing results (381-390 of 480) with videos related to

Pageof 48
Sort By:
Scientific Reports|April 12, 2023
Application of Mendelian randomization to explore the causal role of the human gut microbiome in colorectal cancerCharlie Hatcher, George Richenberg, Samuel Waterson, et al.
BMC Genomics|April 25, 2024
Germline genetic regulation of the colorectal tumor immune microenvironmentStephanie L Schmit, Ya-Yu Tsai, Joseph D Bonner, et al.
Science Translational Medicine|December 3, 2011
Personalized oncology through integrative high-throughput sequencing: a pilot studySameek Roychowdhury, Matthew K Iyer, Dan R Robinson, et al.
Nature Communications|May 30, 2025
Multi-tissue expression and splicing data prioritise anatomical subsite- and sex-specific colorectal cancer susceptibility genesEmma Hazelwood, Daffodil M Canson, Benedita Deslandes, et al.
JCO Precision Oncology|July 29, 2021
Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer RiskGregory E Idos, Allison W Kurian, Charité Ricker, et al.
JAMA Oncology|July 7, 2015
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary MelanomaNancy E Thomas, Sharon N Edmiston, Audrey Alexander, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 21, 2025
Association of Genetic Liability to Allergic Diseases with Overall and Early-Onset Colorectal Cancer Risk: A Mendelian Randomization StudySaleh Alduhayh, Ruhina Shirin Laskar, Xia Jiang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 23, 2017
Quantifying the Genetic Correlation between Multiple Cancer TypesSara Lindström, Hilary Finucane, Brendan Bulik-Sullivan, et al.
American Journal of Human Genetics|November 28, 2002
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish populationW D Foulkes, I Thiffault, S B Gruber, et al.
The British Journal of Dermatology|December 8, 2020
Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysisT Graier, W Salmhofer, C Jonak, et al.
Pageof 48

Showing results (381-390 of 480) with videos related to

Sort By:
Pageof 48
Scientific Reports|April 12, 2023
Application of Mendelian randomization to explore the causal role of the human gut microbiome in colorectal cancerCharlie Hatcher, George Richenberg, Samuel Waterson, et al.
BMC Genomics|April 25, 2024
Germline genetic regulation of the colorectal tumor immune microenvironmentStephanie L Schmit, Ya-Yu Tsai, Joseph D Bonner, et al.
Science Translational Medicine|December 3, 2011
Personalized oncology through integrative high-throughput sequencing: a pilot studySameek Roychowdhury, Matthew K Iyer, Dan R Robinson, et al.
Nature Communications|May 30, 2025
Multi-tissue expression and splicing data prioritise anatomical subsite- and sex-specific colorectal cancer susceptibility genesEmma Hazelwood, Daffodil M Canson, Benedita Deslandes, et al.
JCO Precision Oncology|July 29, 2021
Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer RiskGregory E Idos, Allison W Kurian, Charité Ricker, et al.
JAMA Oncology|July 7, 2015
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary MelanomaNancy E Thomas, Sharon N Edmiston, Audrey Alexander, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 21, 2025
Association of Genetic Liability to Allergic Diseases with Overall and Early-Onset Colorectal Cancer Risk: A Mendelian Randomization StudySaleh Alduhayh, Ruhina Shirin Laskar, Xia Jiang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 23, 2017
Quantifying the Genetic Correlation between Multiple Cancer TypesSara Lindström, Hilary Finucane, Brendan Bulik-Sullivan, et al.
American Journal of Human Genetics|November 28, 2002
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish populationW D Foulkes, I Thiffault, S B Gruber, et al.
The British Journal of Dermatology|December 8, 2020
Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysisT Graier, W Salmhofer, C Jonak, et al.
Pageof 48